Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Olodaterol + Tiotropium in Healthy Volunteers
NCT02259959Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2007
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing BI 1744 CL + Tiotropium with Placebo (2 arms). Primary endpoints: Number of subjects with clinically relevant findings in physical examination, Number of subjects with clinically relevant findings in vital signs and 5 more. Started Apr 2007; status: completed.
02
Drugs
olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02259959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259959.